Results 1 to 10 of about 242,618 (145)

Network meta-analysis of catheter ablation, rhythm control, and rate control strategies in atrial fibrillation with heart failure impact on mortality, cardiac function, and quality of life [PDF]

Frontiers in Medicine
ObjectiveThis network meta-analysis evaluated the comparative efficacy and safety of catheter ablation (CA), rhythm control (RhC), rate control (RC), and combined rhythm and rate control (Rh + RC) in patients with heart failure (HF) and atrial ...
Huize Gao, JiTong Li, Keying Yu, Lingyu Xu, Da Song, Tiejun Liu, Qian Wei, Aidong Liu   +7 more
doaj   +2 more sources

Atrial Fibrillation: Rate Versus Rhythm Control. [PDF]

HCA Healthc J Med, 2023
Description Atrial fibrillation (AF) remains the most common arrhythmia worldwide and is expected to affect approximately 12 million individuals in the United States alone by 2030. Thromboembolic events remain a feared complication of AF and should be treated and risk-stratified utilizing the CHA2DS2-VASc scoring system.
Vargas CE, Bhatnagar M, Ahmed H, Flynn MG, Alexander T.   +4 more
europepmc   +3 more sources

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies [PDF]

Current Issues in Molecular Biology
Diabetes mellitus and atrial fibrillation (AF) frequently coexist, creating a complex bidirectional relationship that exacerbates cardiovascular risk and challenges clinical management.
Konstantinos Grigoriou, Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Theofilis, Dimitrios Patoulias, Efstratios Karagiannidis, Barbara Fyntanidou, Antonios P. Antoniadis, Nikolaos Fragakis   +8 more
doaj   +2 more sources

Revitalizing brain perfusion: Unveiling advancements through rhythm control strategies in atrial fibrillation—A systematic review [PDF]

Journal of Arrhythmia
Background Recent evidence suggests an elevated risk of cognitive impairment and dementia in individuals with atrial fibrillation (AF), irrespective of stroke occurrence. AF, known to reduce brain perfusion, particularly through silent cerebral ischemia,
Shinta Dewi Rasti, Adra Achirultan Ramainaldo Sugiarto, Audia Putri Amalia Nuryandi, Militanisa Zamzara Arvianti, Romadhana Trisnha Yomara, Jeffri Nagasastra, Rerdin Julario, Rosi Amrilla Fagi, Diah Mustika Hesti Windrati   +8 more
doaj   +2 more sources

Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The purpose of the RAFAS (Risk and Benefits of Urgent Rhythm Control of Atrial Fibrillation in Patients With Acute Stroke) trial was to explore the risks and benefits of early rhythm control in patients with newly documented atrial ...
Junbeom Park, Jaemin Shim, Jung Myung Lee, Jin‐Kyu Park, JoonNyung Heo, Yoonkyung Chang, Tae‐Jin Song, Dong‐Hyeok Kim, Hye Ah Lee, Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Young Dae Kim, Hyo Suk Nam, Boyoung Joung, Moon‐Hyoung Lee, Ji Hoe Heo, Hui‐Nam Pak   +17 more
doaj   +1 more source

The Optimal Management of Patients with Atrial Fibrillation and Acute Heart Failure in the Emergency Department

Medicina, 2023
Atrial fibrillation (AF) and acute heart failure (AHF) are two closely interrelated conditions that frequently coexist in a manifold manner, with AF serving either as the causative factor or as the consequence or even as an innocent bystander.
Maria Velliou, Elias Sanidas, Antonis Diakantonis, Ioannis Ventoulis, John Parissis, Effie Polyzogopoulou   +5 more
doaj   +1 more source

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients

Medicina, 2022
Atrial fibrillation (AF) and Heart failure (HF) constitute two frequently coexisting cardiovascular diseases, with a great volume of the scientific research referring to strategies and guidelines associated with the best management of patients suffering ...
Ioanna Koniari, Eleni Artopoulou, Dimitrios Velissaris, Virginia Mplani, Maria Anastasopoulou, Nicholas Kounis, Cesare de Gregorio, Grigorios Tsigkas, Arun Karunakaran, Panagiotis Plotas, Ignatios Ikonomidis   +10 more
doaj   +1 more source

Rhythm control and cardioversion [PDF]

Heart, 2007
The three main aims of treatment for paroxysmal atrial fibrillation are: (1) to suppress paroxysms of atrial fibrillation and maintain long-term sinus rhythm; (2) to control heart rate during paroxysms of atrial fibrillation if they occur; and (3) to prevent the complications associated with paroxysmal atrial fibrillation—that is, stroke and ...
N, Sulke, F, Sayers, G Y H, Lip
openaire   +2 more sources

Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation

Journal of Cardiovascular Development and Disease, 2022
The aim of this research was to evaluate if patients with chronic kidney disease (CKD) and mild or mild to moderate depression of renal function have an increased risk of atrial fibrillation (AF) recurrences after cryoballoon (CB) ablation.
Giuseppe Boriani, Saverio Iacopino, Giuseppe Arena, Paolo Pieragnoli, Roberto Verlato, Massimiliano Manfrin, Giulio Molon, Giovanni Rovaris, Antonio Curnis, Giovanni Battista Perego, Antonio Dello Russo, Maurizio Landolina, Marco Vitolo, Claudio Tondo, on behalf of the 1STOP ClinicalService Investigators   +14 more
doaj   +1 more source

Atrial fibrillation in the elderly population: Challenges and management considerations

Journal of Arrhythmia, 2021
Importance Atrial fibrillation is the most clinically significant arrhythmia in humans when viewed both from a global and also a national perspective. In the United States, approximately 2.7‐6.1 million people are estimated to have atrial fibrillation ...
Mohammed Salih, Osama Abdel‐Hafez, Ramzi Ibrahim, Rajiv Nair   +3 more
doaj   +1 more source